Research and Development Team Advantage: Leading the Way in Innovation and Technology
At Kangxin Biotechnology, our Research and Development (R&D) team is the cornerstone of our success and innovation. Composed of seasoned scientists, clinical experts, and industry elites, our R&D team possesses a strong academic background and extensive practical experience across various fields such as biopharmaceuticals, molecular biology, cell biology, and genetics.
World-Class Leadership in R&D
Our R&D team is led by renowned experts who are leaders in their respective fields:
-
Professor Zhu Yizhun – Academician of the European Academy of Sciences, who is currently the Associate Vice President of the University of Macau, Dean of the School of Pharmacy, and Director of the Institute of Traditional Chinese Medicine. Professor Zhu is a distinguished Chair Professor and a practicing general practitioner at the University of Macau Medical Center.
-
Dr. Suguro Rinko – A renowned biopharmaceutical innovation expert with a wealth of experience in drug development, particularly in molecular pharmacology. Dr. Suguro plays a pivotal role in advancing cutting-edge biopharmaceutical solutions.
-
Dr. He Xianliang – Chief Technology Officer, with over 15 years of experience in drug R&D. Dr. He is also a senior engineer at the national level in China and has worked extensively in leading R&D teams for innovative medical solutions.
State-of-the-Art R&D Centers
Kangxin Biotechnology has established two world-class R&D centers located in Guangzhou and Hangzhou. These centers are equipped with advanced research tools and technologies that drive our innovation and ensure the development of superior products. Our team is committed to advancing cutting-edge research in areas such as nicotine delivery systems, health supplements, and functional oral films.
Industry-Leading Position
Kangxin Biotechnology is recognized as a leading company in the oral strip and functional chewing gum technology sector in China. We have:
-
An internationally recognized oral mucosal delivery technology platform, which is at the forefront of biopharmaceutical innovations.
-
Production capabilities and R&D strength that are among the top in Asia.
-
Established multiple intelligent GMP production bases in locations such as Guangzhou and Hebei to meet global market demands.
Core Technological Barriers
Our R&D team's core technology lies in the self-developed oral delivery technology platform. This platform allows us to develop a range of cross-industry products, from nicotine-based solutions to nutritional health products. We have multiple international patents and trademarks, which further enhance our position in the global marketplace.
Our diverse product pipeline spans areas such as:
-
Nicotine oral films and functional chewing gums, with a focus on health benefits and improved bioavailability.
-
Cross-disciplinary product lines, leveraging advanced delivery technologies for a wide range of applications, from smoking cessation aids to nutraceutical products.
-
International patents that protect our innovative formulations and delivery methods.
Commitment to Excellence and Innovation
Our R&D team is constantly evolving to stay ahead of global trends, with a focus on innovation, technology, and user experience. We pride ourselves on the high level of expertise within our team, which ensures that every product we bring to market is the result of rigorous research, testing, and quality control.
Conclusion
Kangxin Biotechnology’s R&D team, led by world-class experts, positions us as a global leader in oral drug delivery and functional chewing gum technologies. With our advanced technology platforms, state-of-the-art R&D centers, and strong industry presence, we continue to push the boundaries of innovation and deliver high-quality, effective solutions to our customers worldwide. Our commitment to excellence in R&D ensures that we are always at the forefront of new developments in biopharmaceuticals, paving the way for a healthier and more effective future.